Acute Rheumatic Fever with Cardiac Involvement (ICD-11: 1B41)

1. Introduction

Acute rheumatic fever with cardiac involvement represents one of the most serious and potentially disabling complications of untreated streptococcal infection. This condition, coded as 1B41 in the International Classification of Diseases in its 11th revision, is characterized by an abnormal immunological response that occurs following pharyngitis caused by Group A beta-hemolytic Streptococcus, specifically affecting cardiac structures.

Cardiac involvement during the acute phase of rheumatic fever constitutes the most concerning manifestation of this disease, as it can result in permanent damage to cardiac valves, myocardium, and pericardium. Rheumatic carditis, as this manifestation is termed, can range from subclinical forms detected only by echocardiography to severe presentations of congestive heart failure.

The clinical importance of this condition transcends the acute episode, since initial cardiac damage can progress to chronic rheumatic heart disease, requiring prolonged medical follow-up and, in advanced cases, complex surgical interventions. Rheumatic carditis is estimated to be responsible for significant cardiovascular morbidity in populations with limited access to primary health care.

Precise coding of code 1B41 is critical for multiple purposes: it enables appropriate epidemiological tracking of the disease, facilitates proper allocation of health care resources, guides secondary prevention policies, and ensures that patients receive necessary cardiological follow-up. The differentiation between rheumatic fever with and without cardiac involvement has direct implications for prognosis and long-term treatment strategies.

2. Correct ICD-11 Code

Code: 1B41

Description: Acute rheumatic fever with cardiac involvement

Parent category: Acute rheumatic fever

Official definition: Rheumatic heart disease (RHD) is the most significant sequela of acute rheumatic fever (ARF). Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are non-suppurative complications of Group A streptococcal pharyngitis due to a delayed immune response.

This specific code should be used when there is clear documentation of cardiac involvement during the acute episode of acute rheumatic fever. Cardiac involvement can manifest in three main forms: pericarditis (inflammation of the pericardium), myocarditis (inflammation of the cardiac muscle), and endocarditis (inflammation of the endocardium, especially of the cardiac valves). Frequently, these three manifestations occur simultaneously, characterizing rheumatic pancarditis.

The ICD-11 classification maintains this code separate from specific chronic manifestations of cardiac valves, which have their own more specific codes. Code 1B41 refers specifically to the acute phase of the disease with active cardiac involvement, usually occurring within two to four weeks after the initial streptococcal infection.

3. When to Use This Code

Code 1B41 should be applied in specific clinical situations where there is confirmation of acute rheumatic fever accompanied by evidence of cardiac involvement:

Scenario 1: Patient with acute rheumatic pancarditis A young patient presents with a recent history of pharyngitis, followed by fever, migratory arthritis, and clinical signs of heart failure. Physical examination reveals a new cardiac murmur, pericardial friction rub, and tachycardia disproportionate to fever. Echocardiography confirms acute mitral regurgitation, pericardial effusion, and ventricular dysfunction. Jones criteria are met with major cardiac manifestations. This is the classic scenario for code 1B41.

Scenario 2: Subclinical carditis detected by echocardiography An adolescent with a diagnosis of acute rheumatic fever based on arthritis and erythema marginatum does not present with cardiac symptoms or audible murmurs on physical examination. However, Doppler echocardiography reveals mild mitral regurgitation with characteristic valve thickening. Even in the absence of clinical cardiac manifestations, echocardiographic evidence of valve involvement justifies the use of code 1B41.

Scenario 3: Rheumatic myocarditis with heart failure A patient with confirmed rheumatic fever develops progressive dyspnea, orthopnea, and peripheral edema. Cardiac evaluation demonstrates cardiomegaly, ventricular gallop, and signs of pulmonary congestion. Cardiac biomarkers are elevated and echocardiography shows left ventricular systolic dysfunction with reduced ejection fraction, without significant valvular disease. Myocarditis as an isolated manifestation still justifies code 1B41.

Scenario 4: Rheumatic pericarditis with effusion A patient meets diagnostic criteria for acute rheumatic fever and develops chest pain typical of pericarditis, with audible pericardial friction rub. Echocardiography confirms moderate pericardial effusion without hemodynamic compromise. Electrocardiogram shows characteristic changes of pericarditis. This isolated cardiac manifestation also requires code 1B41.

Scenario 5: Recurrence of rheumatic fever with new cardiac involvement A patient with a previous history of rheumatic fever without carditis presents with a new acute episode, this time with evidence of valvular endocarditis. Even though it is a recurrence, the new cardiac involvement during the acute episode justifies code 1B41 for this specific event.

Scenario 6: Rheumatic carditis diagnosed during investigation of new murmur During routine examination, a new cardiac murmur is detected in a patient who had recent pharyngitis. Subsequent investigation confirms acute rheumatic fever through laboratory and clinical criteria, with echocardiography demonstrating acute mitral valvulitis. Even though the diagnosis is made retrospectively, code 1B41 is appropriate.

4. When NOT to Use This Code

Code 1B41 should not be used when the clinical presentation represents chronic sequelae or specific manifestations of rheumatic heart disease, even if these originate from previous episodes of acute rheumatic fever:

Rheumatic mitral stenosis: When the patient presents with established mitral stenosis as a chronic sequela, without evidence of acute rheumatic activity, the specific code for this chronic valvular condition should be used, not 1B41.

Rheumatic mitral insufficiency: Chronic mitral regurgitation resulting from a previous episode of acute rheumatic fever, in the absence of active acute carditis, requires specific coding for the established valvulopathy.

Rheumatic mitral prolapse: This chronic structural alteration of the mitral valve, a consequence of previous rheumatic damage, has its own code and should not be confused with the acute episode.

Combinations of chronic valvular lesions: Patients with mitral stenosis combined with insufficiency, or other combinations of established valvular lesions, should receive specific codes for these chronic valvulopathies.

Rheumatic aortic lesions: Both aortic stenosis and insufficiency of rheumatic origin, when established chronically, have specific codes distinct from 1B41.

Rheumatic tricuspid and pulmonary lesions: Although less common, tricuspid and pulmonary valvulopathies of rheumatic origin, when chronic, also require specific coding.

Critical differentiation: Code 1B41 is exclusive for the acute episode of acute rheumatic fever with active cardiac involvement. Once the acute process resolves and the patient remains with chronic valvular sequelae, the coding should reflect the specific established valvulopathy. Patients under outpatient follow-up for chronic rheumatic heart disease, even while on secondary prophylaxis, should not be coded with 1B41 at routine visits unless they present with acute reactivation of the disease.

Additionally, code 1B41 should not be used for other causes of carditis or valvulopathies, such as infectious endocarditis, viral carditis, congenital or degenerative valvulopathies, even if the patient has a remote history of acute rheumatic fever.

5. Coding Step by Step

Step 1: Assess diagnostic criteria

The diagnosis of acute rheumatic fever with cardiac involvement is based primarily on the Revised Jones Criteria. To use code 1B41, one must first confirm the diagnosis of rheumatic fever through the presence of:

Evidence of prior streptococcal infection: Documented by positive oropharyngeal culture, positive rapid streptococcal antigen test, or elevated anti-streptococcal antibody titers (ASLO, anti-DNAse B). This is a fundamental requirement.

Major manifestations: Carditis must be present as one of the major manifestations. Clinically, it may manifest as new or altered cardiac murmurs, cardiomegaly, congestive heart failure, pericardial friction rub, or specific echocardiographic changes.

Mandatory complementary evaluation: Doppler echocardiography is essential to document the type and severity of cardiac involvement. Ventricular function, presence of valvular regurgitation or stenosis, valvular thickening, pericardial effusion, and signs of myocarditis should be assessed.

Additional diagnostic tools: Electrocardiogram to assess arrhythmias and conduction abnormalities (PR interval prolongation is common), chest X-ray to assess cardiomegaly and pulmonary congestion, and inflammatory markers (ESR, CRP) to confirm systemic inflammatory activity.

Step 2: Verify specifiers

After confirming the diagnosis, it is necessary to adequately characterize the cardiac involvement:

Type of carditis: Identify whether there is isolated pericarditis, myocarditis, endocarditis (valvulitis), or pancarditis. This information, although it does not change the main code, is fundamental for complete clinical documentation.

Severity of involvement: Classify as mild, moderate, or severe based on clinical and echocardiographic criteria. The presence of congestive heart failure indicates greater severity.

Valves affected: Document which valves are involved (mitral is the most common, followed by aortic) and the type of lesion (regurgitation is more common in the acute phase than stenosis).

Duration of episode: Record whether it is the first episode or a recurrence, and how long symptoms have been present.

Step 3: Differentiate from other codes

1B40 - Acute rheumatic fever without mention of cardiac involvement: This code should be used when the patient meets criteria for acute rheumatic fever, but there is no clinical or echocardiographic evidence of cardiac involvement. The key difference is the complete absence of signs of carditis, whether clinical or subclinical. If there is any evidence of cardiac involvement, even if minimal and detected only by echocardiography, the correct code is 1B41, not 1B40.

1B42 - Rheumatic chorea: This code is specific for the neurological manifestation of rheumatic fever, characterized by involuntary movements, motor incoordination, and emotional lability. The key difference is the predominance of the neurological manifestation. It is important to note that a patient may have both carditis and chorea simultaneously; in this case, both codes may be applied if clinical documentation supports both manifestations as significant.

Step 4: Required documentation

Checklist of mandatory information:

Documented evidence of prior streptococcal infection (test results)
Detailed description of cardiovascular examination (presence or absence of murmurs, heart rate, signs of heart failure)
Echocardiogram result with specific description of findings
Other Jones criteria present (arthritis, chorea, erythema marginatum, subcutaneous nodules)
Inflammatory marker results
Electrocardiogram with interpretation
Assessment of severity of cardiac involvement
Treatment instituted and therapeutic response

How to document appropriately: Documentation should clearly specify "acute rheumatic fever with carditis" or "acute rheumatic fever with cardiac involvement," detailing the specific cardiac manifestations found. Avoid vague terms such as "cardiac murmur" without additional specification. Always include complete echocardiographic findings, as these are fundamental for accurate coding.

6. Complete Practical Example

Clinical Case:

Maria, 14 years old, previously healthy, is brought to the emergency department with a complaint of fever for five days, pain and swelling in migratory joints (starting in the knees, then ankles and now wrists) and progressive fatigue. The mother reports that approximately three weeks ago the patient had "severe sore throat" that improved spontaneously after a few days, without seeking medical care at that time.

On physical examination: patient in fair general condition, febrile (38.5°C), tachycardic (HR: 120 bpm). Wrist joints edematous, warm and tender to palpation. Cardiovascular examination reveals 3+/6+ systolic murmur at the mitral focus, radiating to the axilla, which the mother states has never been mentioned before. Pulmonary auscultation with crackles at the bases. No other significant abnormalities.

Complementary tests ordered:

Laboratory: Leukocytosis (15,000/mm³), ESR 80 mm/1st hour, CRP 45 mg/L, ASLO 800 IU/mL (reference value <200). Oropharyngeal culture not performed due to time elapsed since pharyngitis.

Electrocardiogram: Sinus tachycardia, PR interval at the upper limit of normal (0.20 sec).

Chest X-ray: Enlarged cardiac area, signs of mild pulmonary congestion.

Doppler Echocardiogram: Moderate mitral regurgitation with central jet, thickening of mitral leaflets, left ventricle with normal dimensions and preserved systolic function (EF 60%), without pericardial effusion, other valves without significant abnormalities.

Diagnostic reasoning:

The patient presents a clear history of recent pharyngitis (possibly streptococcal) followed by manifestations compatible with acute rheumatic fever. Meets Jones criteria: two major manifestations (carditis evidenced by new murmur and echocardiographic changes + migratory arthritis) associated with evidence of prior streptococcal infection (elevated ASLO) and minor manifestations (fever, elevated ESR and CRP, prolonged PR interval).

Cardiac involvement is clearly documented through the new murmur, signs of mild pulmonary congestion and, mainly, by moderate mitral regurgitation with characteristic valvular changes on echocardiogram. This is acute rheumatic endocarditis (mitral valvulitis).

Coding justification:

The diagnosis is acute rheumatic fever with significant cardiac involvement, characterized by endocarditis (valvulitis) of the mitral valve. This is not an established chronic valvular disease, but acute injury occurring in the context of the current rheumatic episode.

Step-by-Step Coding:

Criteria analysis:

Evidence of streptococcal infection: Present (elevated ASLO)
Major manifestations: Carditis (new murmur + echocardiographic changes) + Migratory arthritis
Minor manifestations: Fever, elevated inflammatory markers, borderline PR interval
Documented cardiac involvement: Yes, through clinical examination and echocardiogram

Code chosen: 1B41

Complete justification: The code 1B41 (Acute rheumatic fever with cardiac involvement) is the correct code because:

The diagnosis of acute rheumatic fever is established by Jones criteria
There is clearly documented cardiac involvement (carditis)
This is an acute episode, not a chronic sequel
Mitral regurgitation is occurring in the context of the acute inflammatory process

Complementary codes: In this specific case, additional codes for chronic valvular disease are not necessary, as the mitral lesion is an integral part of the acute process. If the patient developed decompensated heart failure requiring intensive care, an additional code for heart failure could be considered.

Documented treatment plan:

Hospital admission for treatment and monitoring
Benzathine penicillin for streptococcal eradication
Anti-inflammatory (acetylsalicylic acid or corticosteroid depending on severity)
Relative rest
Secondary prophylaxis with monthly benzathine penicillin after discharge
Regular cardiology follow-up

7. Related Codes and Differentiation

Within the Same Category:

1B40: Acute rheumatic fever without mention of cardiac involvement

When to use 1B40 vs. 1B41: Code 1B40 should be used when the patient presents with acute rheumatic fever confirmed by diagnostic criteria, but without any evidence of cardiac compromise. This means absence of new cardiac murmurs, normal echocardiogram (without valvular regurgitation, without pericardial effusion, without ventricular dysfunction) and absence of symptoms or signs of carditis.

Main difference: The presence or absence of cardiac involvement is the dividing line between these codes. Even subclinical carditis detected only by echocardiography (such as mild mitral regurgitation without audible murmur) already qualifies for code 1B41. Code 1B40 is reserved for cases where the heart is completely spared, typically when the diagnosis is based on other major manifestations such as arthritis, chorea, erythema marginatum or subcutaneous nodules, without associated carditis.

1B42: Rheumatic chorea

When to use 1B42 vs. 1B41: Code 1B42 is specific for the neurological manifestation of rheumatic fever, known as Sydenham's chorea. It is characterized by involuntary movements, motor incoordination, muscle weakness and emotional instability. This code should be used when chorea is the predominant manifestation or when it is desired to specifically highlight this neurological complication.

Main difference: The fundamental difference lies in the organ system primarily affected: cardiac in 1B41 versus neurological in 1B42. It is important to note that these manifestations may coexist in the same patient. In cases where there is both significant carditis and chorea, both codes may be appropriate, depending on local coding guidelines and the purpose of coding. Chorea often appears later than other manifestations and may be the only manifestation present in some cases.

Differential Diagnoses:

Infective endocarditis: May present with new cardiac murmurs and fever, but usually there is documented bacteremia, larger valvular vegetations on echocardiogram, embolic phenomena and absence of other rheumatic fever criteria. A history of prior streptococcal infection and the presence of migratory arthritis favor rheumatic fever.

Juvenile idiopathic arthritis: May present with arthritis and fever, but arthritis tends to be more persistent (non-migratory), inflammatory markers may be even more elevated, and there is no typical cardiac involvement nor history of streptococcal infection.

Viral myocarditis: May cause ventricular dysfunction and heart failure symptoms, but generally there is no significant valvulitis, the history is of recent viral infection (not streptococcal), and other manifestations of rheumatic fever are lacking.

Idiopathic pericarditis: May cause chest pain, pericardial friction rub and pericardial effusion, but occurs in isolation, without the other systemic manifestations of rheumatic fever.

8. Differences with ICD-10

Equivalent ICD-10 code: I01 (Acute rheumatic fever with cardiac involvement), with subdivisions such as I01.0 (Acute rheumatic pericarditis), I01.1 (Acute rheumatic endocarditis), I01.2 (Acute rheumatic myocarditis) and I01.9 (Acute rheumatic fever with cardiac involvement, unspecified).

Main changes in ICD-11:

The transition from ICD-10 to ICD-11 brought some important modifications in the coding of acute rheumatic fever with cardiac involvement. In ICD-10, there were more specific subdivisions for each type of carditis (pericarditis, endocarditis, myocarditis), while ICD-11 uses the single code 1B41 for all forms of acute cardiac involvement.

ICD-11 adopts a more simplified approach, grouping all manifestations of acute rheumatic carditis under a single code, with detailed specification of the type of involvement being made in complementary clinical documentation, not through different codes. This change reflects the recognition that, in clinical practice, there is frequently an overlap of different forms of carditis (pancarditis), making the separation into distinct codes less useful.

Practical impact of these changes:

The simplification of coding facilitates the clinical coding process, reducing the possibility of errors from incorrect choice between subtypes. However, it requires more detailed clinical documentation to specify the exact type of carditis present, since this information will no longer be implicit in the code. Health information systems need to adapt to capture these nuances through additional descriptive fields.

For epidemiological and research purposes, the change may impact direct comparability with historical data coded in ICD-10, necessitating mapping and conversion strategies. Healthcare professionals and coders should be aware of these differences during the transition period between classifications.

9. Frequently Asked Questions

How is acute rheumatic fever with cardiac involvement diagnosed?

The diagnosis is based on the Revised Jones Criteria, which require evidence of prior streptococcal infection (through culture, rapid test, or serology) associated with specific major and minor manifestations. For cardiac involvement, detailed cardiovascular physical examination is essential, looking for new murmurs, signs of heart failure, or pericardial friction rub. Doppler echocardiography is fundamental, as it can detect subclinical carditis not apparent on physical examination, identifying valvular regurgitation, valvular thickening, ventricular dysfunction, or pericardial effusion. Complementary tests include electrocardiogram, chest X-ray, inflammatory markers, and anti-streptococcal antibodies. The combination of compatible clinical history, laboratory evidence of streptococcal infection, and characteristic cardiovascular findings establishes the diagnosis.

Is treatment available in public health systems?

Yes, treatment of acute rheumatic fever with cardiac involvement is widely available in public health systems in various countries. Essential medications include antibiotics (penicillin), anti-inflammatory agents (acetylsalicylic acid or corticosteroids), and medications for heart failure when necessary. Benzathine penicillin, used for both initial eradication and secondary prophylaxis, is a low-cost medication and widely available. Echocardiography, essential for diagnosis and follow-up, is generally available in referral hospitals. The main challenge in some contexts is not the availability of treatment itself, but timely access to health services for early diagnosis and adherence to prolonged secondary prophylaxis.

How long does treatment last?

Treatment of the acute phase generally lasts from two to twelve weeks, depending on the severity of cardiac involvement. Anti-inflammatory agents are maintained until normalization of inflammatory markers and resolution of clinical manifestations. However, the most important aspect is secondary prophylaxis, which must be maintained for years or decades. Patients with carditis should receive monthly benzathine penicillin for at least ten years after the last episode or until age 40 (whichever is longer), according to international recommendations. In cases of severe carditis with residual valvular damage, prophylaxis may be lifelong. Regular cardiology follow-up is also maintained indefinitely to monitor the evolution of possible valvular sequelae.

Can this code be used in medical certificates?

Yes, code 1B41 can and should be used in medical certificates when appropriate, especially during the acute phase of the disease. Acute rheumatic fever with cardiac involvement frequently requires time off from school or work activities during the acute treatment period, particularly when there is significant carditis or heart failure. Rest is an important part of initial treatment. The duration of time off should be individualized based on the severity of cardiac involvement, response to treatment, and the type of activity the patient performs. Intense physical activities should be avoided until complete resolution of carditis and normalization of inflammatory parameters, which may take weeks to months.

Can rheumatic fever with carditis recur?

Yes, patients who have had an episode of rheumatic fever have an increased risk of recurrence if exposed again to Group A Streptococcus. Each new episode can cause additional cardiac damage, worsening previous valvular lesions or creating new ones. Therefore, secondary prophylaxis with benzathine penicillin is fundamental. Studies demonstrate that adequate prophylaxis drastically reduces the risk of recurrence. Patients with a history of carditis have an indication for more prolonged prophylaxis precisely because the risk of cumulative cardiac damage in recurrences is greater. Warning signs of recurrence include new pharyngitis, return of arthritis, fever, or appearance of new cardiac murmurs.

Are children more affected than adults?

Yes, acute rheumatic fever predominantly affects children and adolescents, with peak incidence between 5 and 15 years of age. This is due to the higher frequency of streptococcal infections in this age group, especially in crowded environments such as schools. Adults can develop rheumatic fever, but it is less common, generally occurring in individuals who did not have adequate access to treatment of streptococcal pharyngitis or who live in conditions of high exposure. Cardiac involvement also tends to be more severe in younger children. Susceptibility decreases with age, and episodes after age 30 are rare, except in cases of reactivation or in populations with high disease prevalence.

What is the difference between acute rheumatic fever and chronic rheumatic heart disease?

Acute rheumatic fever (code 1B41 when there is cardiac involvement) refers to the active inflammatory episode that occurs weeks after streptococcal infection, with systemic manifestations such as fever, arthritis, and active carditis. It is an acute inflammatory process lasting weeks to a few months. Chronic rheumatic heart disease, on the other hand, refers to permanent cardiac sequelae, especially established valvular lesions (stenosis or insufficiency), which persist after resolution of the acute phase. A patient may have had acute rheumatic fever years ago and now live with chronic rheumatic heart disease, requiring continuous cardiology follow-up. The coding differs: 1B41 for the acute phase with carditis, and specific codes for valvular disease for chronic sequelae.

Is it possible to prevent rheumatic fever with cardiac involvement?

Yes, prevention is entirely possible through two main strategies. Primary prevention consists of appropriate diagnosis and treatment of streptococcal pharyngitis with appropriate antibiotics (penicillin or amoxicillin), which prevents the development of rheumatic fever. Secondary prevention, for those who have already had rheumatic fever, consists of prophylaxis with monthly benzathine penicillin, which prevents new streptococcal infections and, consequently, recurrences of rheumatic fever. Public health measures such as improvement of housing conditions, reduction of crowding, facilitated access to health services, and screening programs for streptococcal pharyngitis in at-risk populations also contribute significantly to the prevention of this potentially serious condition.

Conclusion:

Accurate coding of acute rheumatic fever with cardiac involvement using code 1B41 is fundamental for the appropriate management of this potentially serious condition. Understanding when to use this code, differentiating it from chronic manifestations and other related conditions, ensures not only the accuracy of medical records, but also ensures that patients receive appropriate cardiology follow-up and the necessary secondary prophylaxis to prevent recurrences and progression of rheumatic heart disease.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-04

Acute Rheumatic Fever with Cardiac Involvement

Partager